ELEVANCE HEALTH, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 532.1 USD | +1.32% |
|
+7.09% | +12.98% |
| 04:56pm | UBS Adjusts Price Target on Elevance Health to $605 From $585, Maintains Buy Rating | MT |
| 03:13pm | Bernstein Adjusts Price Target on Elevance Health to $665 From $629 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Elevance Health, Inc. is the American leading of health insurance. The group provides a broad range of medical and specialty products and services (life and disability insurance, medication, dental, vision insurance system and behavioral care insurance system, long-term health care insurance, medical expenses management, etc.).
Elevance Health, Inc. is an independent licensee of the Blue Cross and Blue Shield Association, an independent association providing health insurance system.
At the end of 2023, the group had nearly 47 million medical members.
Sector
Managed Healthcare
Calendar
2024-05-15
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
525.2
USD
Average target price
595.3
USD
Spread / Average Target
+13.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.98% | 122B | |
| +17.47% | 98.93B | |
| +1.40% | 39.45B | |
| -28.32% | 39.16B | |
| +1.98% | 21.15B | |
| -12.80% | 3.06B | |
| -39.61% | 964M | |
| -34.48% | 313M |
- Stock Market
- Equities
- ELV Stock
- News Elevance Health, Inc.
- Anthem : Barclays Adjusts Price Target on Anthem to $485 From $450, Maintains Overweight Rating
